Effects of Sacubitril/Valsartan on Glycemic Control in Japanese Patients With Heart Failure and/or Hypertension

Background: Post hoc analysis of the PARADIGM-HF trial showed that sacubitril/valsartan (S/V) was more effective than enalapril in lowering HbA1c in patients with heart failure and diabetes. Methods and Results: In the present study, the effect of S/V on glycemic control was retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sazawa, Kahomi, Ohno, Kohei, Yamashita, Tomohisa, Ino, Shoya, Shibata, Satoru, Itoh, Takahito, Hotta, Hiroyuki, Matsumoto, Tomoaki, Ooiwa, Hitoshi, Kubo, Hirofumi, Miki, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726527/
https://www.ncbi.nlm.nih.gov/pubmed/36530836
http://dx.doi.org/10.1253/circrep.CR-22-0109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726527/
https://www.ncbi.nlm.nih.gov/pubmed/36530836
http://dx.doi.org/10.1253/circrep.CR-22-0109

Ejemplares similares